204 related articles for article (PubMed ID: 29375468)
1. Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists.
Ysrraelit MC; Fiol MP; Gaitán MI; Correale J
Front Neurol; 2017; 8():729. PubMed ID: 29375468
[TBL] [Abstract][Full Text] [Related]
2. Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges.
Marin CE; Kfouri PP; Callegaro D; Lana-Peixoto MA; Neto APG; Vasconcelos CCF; d'Almeida JAC; Gonçalves MVM; Mendes MF; Parolin MKF; Nascimento O; da Gama PD; Dias-Carneiro RPC; Dias RM; Damasceno A; San Martin G; Becker J;
Mult Scler Relat Disord; 2021 May; 50():102806. PubMed ID: 33588316
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire.
Uchmanowicz I; Jankowska-Polańska B; Wleklik M; Rosinczuk-Tonderys J; Dębska G
Pneumonol Alergol Pol; 2014; 82(1):10-7. PubMed ID: 24391066
[TBL] [Abstract][Full Text] [Related]
4. Cross-cultural Adaptation and Validation of the Stoma Quality of Life Questionnaire for Patients With a Colostomy or Ileostomy in Brazil: A Cross-sectional Study.
Lívia de Oliveira A; Loures Mendes L; Pereira Netto M; Gonçalves Leite IC
Ostomy Wound Manage; 2017 May; 63(5):34-41. PubMed ID: 28570247
[TBL] [Abstract][Full Text] [Related]
5. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.
Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
Arch Neurol; 2004 May; 61(5):679-86. PubMed ID: 15148144
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment.
Vermersch P; de Seze J; Delisse B; Lemaire S; Stojkovic T
Mult Scler; 2002 Oct; 8(5):377-81. PubMed ID: 12356203
[TBL] [Abstract][Full Text] [Related]
7. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P
Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068
[TBL] [Abstract][Full Text] [Related]
8. [A study of the quality of life in cases of multiple sclerosis].
Delgado-Mendilívar JM; Cadenas-Díaz JC; Fernández-Torrico JM; Navarro-Mascarell G; Izquierdo G
Rev Neurol; 2005 Sep 1-15; 41(5):257-62. PubMed ID: 16138280
[TBL] [Abstract][Full Text] [Related]
9. Relationship between quality of life and dysarthria in patients with multiple sclerosis.
Piacentini V; Mauri I; Cattaneo D; Gilardone M; Montesano A; Schindler A
Arch Phys Med Rehabil; 2014 Nov; 95(11):2047-54. PubMed ID: 24835754
[TBL] [Abstract][Full Text] [Related]
10. Perceptions of health status in multiple sclerosis patients and their doctors.
Kremenchutzky M; Walt L
Can J Neurol Sci; 2013 Mar; 40(2):210-8. PubMed ID: 23419570
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.
Janardhan V; Bakshi R
Arch Neurol; 2000 Oct; 57(10):1485-91. PubMed ID: 11030802
[TBL] [Abstract][Full Text] [Related]
12. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis.
Rothwell PM; McDowell Z; Wong CK; Dorman PJ
BMJ; 1997 May; 314(7094):1580-3. PubMed ID: 9169401
[TBL] [Abstract][Full Text] [Related]
13. [Quality of life in patients with schizophrenia: a study of 100 cases].
Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids.
Rakusa M; Chataway J; Hardy TA
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765052
[TBL] [Abstract][Full Text] [Related]
15. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing pre-stroke and post-stroke quality of life among stroke survivors in a lower middle-income country.
Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Liyanage SN
Neurol Sci; 2018 Feb; 39(2):287-295. PubMed ID: 29103178
[TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis.
Arroyo González R; Kita M; Crayton H; Havrdova E; Margolin DH; Lake SL; Giovannoni G;
Mult Scler; 2017 Sep; 23(10):1367-1376. PubMed ID: 27885061
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of health-related quality of life in dialysis patients. Personal experience using questionnaire SF-36].
Kusztal M; Nowak K; Magott-Procelewska M; Weyde W; Penar J
Pol Merkur Lekarski; 2003 Feb; 14(80):113-7. PubMed ID: 12728668
[TBL] [Abstract][Full Text] [Related]
19. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires.
Fernández O; Baumstarck-Barrau K; Simeoni MC; Auquier P;
Mult Scler; 2011 Oct; 17(10):1238-49. PubMed ID: 21669936
[TBL] [Abstract][Full Text] [Related]
20. Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.
Bertolotto A; Arroyo R; Celius EG; Comi G; Havrdova EK; Honeycutt WD; Hunter SF; Izquierdo G; Kornek B; Miller T; Mitsikostas DD; Singer BA; Ziemssen T; Chung L; Daizadeh N; Afsar S; Hashemi L; Senior P
Neurol Ther; 2020 Dec; 9(2):443-457. PubMed ID: 32410147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
